亚太地区血尿治疗市场预测至 2028 年 - COVID-19 影响和治疗（药物、疗法等）、适应症（尿路感染、肾结石、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎、创伤）的区域分析、剧烈运动、多囊肾、子宫内膜异位症和月经）、类型（肉眼血尿、镜下血尿、特发性血尿和慢跑者血尿）、最终用户（医院、诊所和门诊手术中心等）
No. of Pages: 181 | Report Code: TIPRE00026249 | Category: Life Sciences
No. of Pages: 181 | Report Code: TIPRE00026249 | Category: Life Sciences
市场介绍
血尿是一种在尿液中发现血液的疾病。一般来说，尿液中不含红细胞，因此可能会导致严重的问题，还可能导致肾结石、尿路感染和其他遗传性疾病。
此外，血尿的患病率很高预计相关迹象将在预测期内促进市场增长。然而，相关适应症的未确诊病例限制了亚太地区血尿治疗市场的增长。
COVID-19 疫情严重影响了旅游业并造成供应链中断；此外，低收入国家由于医疗基础设施短缺而面临更多挑战。韩国、马来西亚、新加坡、菲律宾和印度已采取限制措施，以防止疾病传播。由于供应链的限制以及制造能力的有限，所有这些因素在短时间内对血尿治疗市场产生了中等程度的影响。 COVID-19患者的肾脏受累可能有多种表现，包括血尿、蛋白尿、脓尿和急性肾损伤（AKI）。据报道，蛋白尿和血尿在 COVID 19 中的患病率高于 AKI。另一方面，AKI 目前是住院 COVID 19 患者的一个令人不安的迹象，也是死亡的主要危险因素。因此，血尿治疗市场受到COVID19的积极影响。
市场概况和动态
亚太地区血尿治疗市场预计将从 2021 年的 2.11 亿美元增至 2028 年的 2.576 亿美元；预计 2021 年至 2028 年复合年增长率为 2.9%。由于慢性适应症患病率上升，医疗保健支出大幅增加。各个经济体的政府正在大力投资改善医疗基础设施。此外，发达经济体的患者逐渐意识到血尿治疗的可能治疗方法和报销情况。血尿是血癌、膀胱癌和肾癌等慢性疾病的最初迹象之一。这些疾病均受到各种健康保险政策的保障，有助于患者轻松治疗并减轻医疗保健的经济负担。因此，提高医疗保健支出和患者对治疗的认识正在推动亚太地区血尿治疗市场的发展。
主要细分市场< /strong>
从类型来看，肉眼血尿细分市场在2020年亚太血尿治疗市场中占据最大份额。从治疗来看，药物细分市场占据了最大份额。 2020年亚太血尿治疗市场份额最大。从适应症来看，尿路感染细分市场占2020年亚太血尿治疗市场最大份额。从最终用户来看，医院细分市场占2020年亚太血尿治疗市场份额最大。
主要来源和上市公司
准备本亚太地区血尿治疗市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库，其中其他的。报告中列出的主要公司包括阿斯利康、百时美施贵宝公司、F. HOFFMANN-LA ROCHE LTD.、葛兰素史克公司、杨森制药、默沙东制药公司和默沙东制药公司。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd 和 Boehringer Ingelheim International GmbH。
购买报告的理由
亚太地区血尿治疗市场细分
作者
治疗
按适应症
按类型
最终用户
按国家/地区
< /p>
提及的公司
Strategic insights for Asia Pacific Hematuria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 211.0 Million |
| Market Size by 2028 | US$ 257.6 Million |
| Global CAGR (2021 - 2028) | 2.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 治疗
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Hematuria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Hematuria Treatment Market is valued at US$ 211.0 Million in 2021, it is projected to reach US$ 257.6 Million by 2028.
As per our report Asia Pacific Hematuria Treatment Market, the market size is valued at US$ 211.0 Million in 2021, projecting it to reach US$ 257.6 Million by 2028. This translates to a CAGR of approximately 2.9% during the forecast period.
The Asia Pacific Hematuria Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Hematuria Treatment Market report:
The Asia Pacific Hematuria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Hematuria Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Hematuria Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Hematuria Treatment Market
